Opioid Peptides Had Complex Effects on Insulin Release in Mice
Beta-endorphin showed biphasic insulin effects (low doses inhibited, high doses stimulated), while met-enkephalin inhibited and dynorphin A stimulated cholinergic insulin release.
Quick Facts
What This Study Found
Beta-endorphin had a dose-dependent biphasic effect on insulin secretion. Low doses inhibited and high doses stimulated insulin release. Met-enkephalin only inhibited. Dynorphin A had no effect.
Key Numbers
How They Did This
Mice received intravenous injections of opioid peptides at doses from 0.06 to 64 nmol/kg, alone or combined with insulin-releasing agents (glucose, carbachol, terbutaline). Plasma insulin was measured.
Why This Research Matters
This shows that the body's natural opioid peptides can fine-tune insulin release. Different opioid types have completely different effects, suggesting precise regulation of blood sugar by the opioid system.
The Bigger Picture
Opioid peptide regulation of insulin adds another layer to metabolic control. This may explain metabolic disturbances in opioid drug users and inform peptide-based diabetes research.
What This Study Doesn't Tell Us
This was an animal study in mice. Intravenous injection does not mimic natural peptide release within the pancreas. Dose-response patterns may differ in humans.
Questions This Raises
- ?Do endogenous opioid levels affect diabetes risk?
- ?Could opioid receptor drugs be used for blood sugar control?
Trust & Context
- Key Stat:
- Peptide-specific insulin effects Each opioid peptide had a distinct pattern of insulin regulation
- Evidence Grade:
- Preliminary animal study with dose-response data across three peptides.
- Study Age:
- Published in 1989 — established opioid peptide roles in insulin regulation.
- Original Title:
- Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
- Published In:
- International journal of pancreatology : official journal of the International Association of Pancreatology, 5(2), 165-78 (1989)
- Authors:
- Ahrén, B
- Database ID:
- RPEP-00102
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Do opioid drugs affect blood sugar?
Yes — this study shows opioid peptides directly regulate insulin release. Chronic opioid use can disrupt blood sugar control through these mechanisms.
What does biphasic mean?
Low doses of beta-endorphin reduced insulin while high doses increased it. The same molecule has opposite effects at different concentrations — a common pattern in hormone signaling.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00102APA
Ahrén, B. (1989). Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.. International journal of pancreatology : official journal of the International Association of Pancreatology, 5(2), 165-78.
MLA
Ahrén, B. "Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.." International journal of pancreatology : official journal of the International Association of Pancreatology, 1989.
RethinkPeptides
RethinkPeptides Research Database. "Effects of beta-endorphin, met-enkephalin, and dynorphin A o..." RPEP-00102. Retrieved from https://rethinkpeptides.com/research/ahren-1989-effects-of-betaendorphin-metenkephalin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.